Liminal BioSciences Inc.

(: LMNL.TO)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Liminal Biosciences engages in clinical-stage research and commercialization of fibrosis treatments. The company operates in two segments: small molecule therapeutics and plasma-derived therapeutics. The small molecule segment develops and commercializes treatments for lung, liver, and kidney conditions. The plasma-derived segment sells proteins and specialty plasma in addition to developing a plasma treatment product. Liminal Biosciences does business in Canada, the U.K., and the U.S., and nearly all of its revenue comes from the plasma-derived therapeutics segment.

Contact Information

Website: www.liminalbiosciences.com
Email: investor@liminalbiosciences.com
Main Phone: +1 450 781-0115
Address: 440, Boulevard Armand-Frappier
Address 2: Suite 300
State: QC
City / Town: Laval
Country: CA
Postal Code: H7V 4B4

Issuer Information

Exchange: TSX
CEO: Kenneth Galbraith
Employees: 300
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A